Healthcare Services Group financials
$20.90+0.58%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.84B | $1.72B | $1.67B | $1.69B | $1.64B | $1.76B | $1.84B | $2.00B | $1.86B | $1.56B |
| Gross profit | $239.4M | $228.1M | $214.7M | $193.3M | $230.6M | $268.0M | $227.9M | $234.4M | $250.6M | $223.2M |
| Gross margin | 13.0% | 13.3% | 12.8% | 11.4% | 14.0% | 15.2% | 12.4% | 11.7% | 13.5% | 14.3% |
| Operating income | $48.5M | $45.0M | $48.0M | $53.0M | $57.5M | $117.2M | $77.9M | $97.8M | $123.9M | $117.8M |
| Net income | $59.1M | $39.5M | $38.4M | $34.2M | $48.5M | $98.7M | $64.6M | $83.5M | $88.2M | $77.4M |
| Net margin | 3.2% | 2.3% | 2.3% | 2.0% | 3.0% | 5.6% | 3.5% | 4.2% | 4.7% | 5.0% |
| Diluted EPS | $0.81 | $0.53 | $0.52 | $0.46 | $0.65 | $1.32 | $0.87 | $1.12 | $1.19 | $1.05 |
| EBITDA | $65.6M | $61.1M | $64.5M | $70.5M | $74.4M | $131.5M | $91.8M | $108.5M | $134.1M | $127.0M |
| Operating cash flow | $145.0M | $30.8M | $43.5M | -$8.2M | $37.1M | $217.2M | $93.6M | $80.0M | $7.6M | $41.4M |
| Free cash flow | $139.2M | $24.5M | $38.1M | -$13.4M | $31.4M | $212.9M | $89.2M | $75.1M | $2.2M | $36.0M |
| Diluted shares | 73.0M | 74.0M | 74.3M | 74.4M | 75.0M | 74.8M | 74.6M | 74.6M | 74.3M | 73.5M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $125.2M | $56.8M | $54.3M | $26.3M | $70.8M | $139.3M |
| Short-term investments | $42.8M | $50.5M | $93.1M | $95.2M | $114.4M | $125.0M |
| Total debt | $0.00 | $0.00 | $25.0M | $25.0M | $0.00 | $0.00 |
| Total assets | $794.3M | $802.8M | $790.7M | $720.8M | $777.5M | $785.0M |
| Total liabilities | $284.0M | $302.8M | $334.0M | $302.6M | $324.9M | $304.6M |
| Shareholders' equity | $510.2M | $499.9M | $456.6M | $418.3M | $452.7M | $480.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology